|Articles|March 1, 2001

March 2001
Volume 7
Issue 3

Physician Perceptions of a National Formulary

Author(s)Peter A. Glassman, MBBS, MSc, Chester B. Good, MD, MPH, Mary E. Kelley, MS

Download PDF: Physician Perceptions of a National Formulary

Articles in this issue

over 25 years ago

Article

Prior-Authorization Requirements for Patient Referrals to Specialists

over 25 years ago

Article

Assessing Safety of New Technology: Conference Looks at Evaluation Process

over 25 years ago

Article

Specialty of Principal Care Physician and Medicare Expenditures in Patients with Coronary Artery Disease:Impact of Comorbidity and Severity

over 25 years ago

Article

Clinical and Economic Outcomes of an Ambulatory Urinary Tract Infection Disease Management Program

over 25 years ago

Article

Renal Effects of Angiotensin-Converting Enzyme Inhibitors That Result in Cost Savings and Improved Patient Outcomes

over 25 years ago

Article

Are Patients' Chief Complaints Generally Specific to One Organ System?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Readability of Hospital Patient Financial Policy Documents

BySamantha Randall, BA,Sumedha Raghu, MS,Ella Cho,Nina Linh Nguyen, MHA,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

July 7th 2026

Physician Perceptions of a National Formulary

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

AI Chatbots Score Below 28% on Colorectal Cancer Questions

5 Notable FDA Approvals From the First Half of 2026

New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment

JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Physician Perceptions of a National Formulary

Articles in this issue

Related Content

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Readability of Hospital Patient Financial Policy Documents

Trending on AJMC

AI Chatbots Score Below 28% on Colorectal Cancer Questions

5 Notable FDA Approvals From the First Half of 2026

New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment

JAK Inhibitors Reshaped Alopecia Areata Care, but Long-Term Data Gaps Remain

Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues